Bank of New York Mellon’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Bank of New York Mellon’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-103,404	Closed	-$230K	–	4500
2021 Q1	$230K	Buy	103,404 +1,976	+2%	+$5.21K	﹤0.01%	4009
2020 Q4	$252K	Buy	101,428 +11,243	+12%	+$24.8K	﹤0.01%	3895
2020 Q3	$222K	Buy	90,185 +350	+0.4%	+$1.02K	﹤0.01%	3812
2020 Q2	$319K	Buy	+89,835	New	+$284K	﹤0.01%	3675
2019 Q2	–	Sell	-74,758	Closed	-$147K	–	4303
2019 Q1	$147K	Buy	74,758 +3,295	+5%	+$6.99K	﹤0.01%	3944
2018 Q4	$94K	Hold	71,463	–	–	﹤0.01%	3970
2018 Q3	$176K	Sell	71,463 -1	-0%	-$3	﹤0.01%	3961
2018 Q2	$240K	Buy	71,464 +973	+1%	+$3.74K	﹤0.01%	3882
2018 Q1	$298K	Hold	70,491	–	–	﹤0.01%	3799
2017 Q4	$233K	Sell	70,491 -341	-0.5%	-$1.24K	﹤0.01%	3886
2017 Q3	$271K	Sell	70,832 -2,527	-3%	-$9.58K	﹤0.01%	3790
2017 Q2	$323K	Buy	+73,359	New	+$301K	﹤0.01%	3790

Other funds holding NYMX

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TEE

Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Bank of New York Mellon's NYMX Position: Q2 2021 in Review

Bank of New York Mellon sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2021, closing a stake of 103,404 shares — an estimated $230K sold.

Bank of New York Mellon first reported a position in NYMX in Q2 2017 and held it in 12 quarters. The position peaked at $323K in Q2 2017. 51 funds tracked by Wall St. Rank hold NYMX as of Q2 2021.

Bank of New York Mellon reported no remaining Nymox Pharmaceutical Corp position as of Q2 2021 after selling out during the quarter.
Bank of New York Mellon sold 103,404 Nymox Pharmaceutical Corp shares in Q2 2021, an estimated $230K.
Bank of New York Mellon first reported a position in Nymox Pharmaceutical Corp in Q2 2017 and held it in 12 quarters.
Bank of New York Mellon's Nymox Pharmaceutical Corp position peaked at $323K in Q2 2017.
51 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2021.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.